A validated surrogate analyte LC-MS/MS assay for quantification of endogenous cortisol in human whole blood

被引:8
|
作者
Agrawal, Karan [1 ]
Voggu, Ramakrishna R. [1 ]
Pisek, Daniel [1 ]
Becht, Steven [2 ]
Chudnovskiy, Ross [1 ]
Dufour, Geraldine Mercier [3 ]
Arfvidsson, Cecilia [4 ]
Thomas, C. Eric [1 ]
机构
[1] Covance Labs Inc, 8211 SciCor Dr, Indianapolis, IN 46214 USA
[2] Covance Labs Inc, 3301 Kinsman Blvd, Madison, WI 53704 USA
[3] Covance Labs Inc, Otley Rd, Harrogate HG3 1PY, England
[4] AstraZeneca R&D, Clin Pharmacol & Safety Sci, Quantitat Pharmacol Clin Pharmacol, Gothenburg, Sweden
关键词
Cortisol; Whole blood; LC-MS/MS; Surrogate analyte; Supported liquid extraction; Bioanalysis; TANDEM MASS-SPECTROMETRY; QUANTITATION; AGREEMENT; PLASMA;
D O I
10.1016/j.jpba.2021.114028
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Cortisol is a steroid hormone that is frequently measured as a marker of stress, inflammation, and immune function. While commonly analyzed in saliva, hair, blood plasma and urine, a recent trend towards whole blood-based at-home collection devices has emerged, which necessitates development of more sensitive assays for cortisol in whole blood. To support the implementation of a patient-centric sampling approach in a drug development program, a fit-for-purpose surrogate analyte-based liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for cortisol in whole blood was developed using C-13(3)-cortisol as a surrogate analyte and cortisol-d6 as the internal standard. The surrogate analyte approach was chosen due to a lack of available cortisol-free whole blood and the absence of appropriately representative surrogate matrices. Samples were prepared using supported liquid extraction, and the LC-MS/MS analysis consisted of a 4.00 min analytical run. The method demonstrated linearity between 0.500 and 500 ng/mL of C-13(3)-cortisol, and accuracy, precision and robustness were all acceptable per current regulatory guidance for bioanalytical method validation of chromatographic assays for cortisol- and C-13(3)-cortisol-based quality control (QC) samples when quantified against a C-13(3)-cortisol calibration curve. The acceptable robustness of cortisol-based QCs when quantified against a C-13(3)-cortisol-based calibration curve also suggests parallelism between the analytes. These results indicate a viable surrogate analyte method, that is fit-for-purpose to analyze whole blood cortisol levels using a surrogate analyte LC-MS/MS approach. Evaluation of patient samples showed very promising comparability between whole blood and plasma cortisol concentrations, suggesting that whole blood could be used in place of or in addition to a plasma-based sampling protocol in clinical trials analyzing cortisol. Overall, this method presents a novel tool that is a first step in supporting the trend towards sample miniaturization and at-home sample collection, and may be readily used in clinical and diagnostic settings. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Validated LC-MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies
    Yoon, Seo Hyun
    Oh, Seul
    Kim, Hwa Suk
    Yi, SoJeong
    Yu, Kyung-Sang
    Jang, In-Jin
    Cho, Joo-Youn
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2015, 53 (08) : 1250 - 1256
  • [42] Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)
    Gomonit, Munchelou M.
    Skillman, Britni
    Swortwood, Madeleine J.
    JOURNAL OF FORENSIC SCIENCES, 2024, 69 (02) : 678 - 687
  • [43] Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach
    Deborah Montenarh
    Markus Hopf
    Hans H. Maurer
    Peter Schmidt
    Andreas H. Ewald
    Analytical and Bioanalytical Chemistry, 2014, 406 : 803 - 818
  • [44] Determination of Anagrelide in Human Plasma by a Validated LC-MS/MS Method
    Svinarov, D.
    Kasabova, L.
    Kostova, K.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 722 - 722
  • [45] DETERMINATION OF METHYLPHENIDATE IN HUMAN PLASMA BY A VALIDATED LC-MS/MS METHOD
    Kasabova, L.
    Svinarov, D.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E62 - E63
  • [46] Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach
    Montenarh, Deborah
    Hopf, Markus
    Maurer, Hans H.
    Schmidt, Peter
    Ewald, Andreas H.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2014, 406 (03) : 803 - 818
  • [47] DETERMINATION OF LEVONORGESTREL IN HUMAN PLASMA BY A VALIDATED LC-MS/MS METHOD
    Svinarov, D.
    Kasabova, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 67 - 67
  • [48] Salivary cortisol by LC-MS/MS.
    Taylor, RL
    Grebe, SK
    Singh, RJ
    CLINICAL CHEMISTRY, 2003, 49 (06) : A131 - A131
  • [49] Development and validation of an LC-MS/MS assay for the quantification of dolutegravir extracted from human hair
    Sykes, Craig
    Blake, Kimberly
    White, Nicole
    Schauer, Amanda P.
    Guzman, Bryan B.
    Cottrell, Mackenzie L.
    Tamraz, Bani
    Kashuba, Angela D. M.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2018, 410 (29) : 7773 - 7781
  • [50] A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extracts
    Robbins, Brian L.
    Nelson, Sarah R.
    Fletcher, Courtney V.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 70 : 378 - 387